128 related articles for article (PubMed ID: 17577796)
1. Epstein-Barr virus-related lymphoproliferative disease after allogeneic bone marrow transplantation for severe aplastic anemia complicated by the syndrome of inappropriate secretion of antidiuretic hormone.
Ostronoff M; Ostronoff F; Florêncio R; Maior AP; Sucupira A; Calixto R; Domingues MC; Tagliari C
Leuk Lymphoma; 2007 Jun; 48(6):1244-6. PubMed ID: 17577796
[No Abstract] [Full Text] [Related]
2. CD20-negative Epstein-Barr virus-associated post-transplant lymphoproliferative disease refractory to rituximab in a patient with severe aplastic anemia.
Muramatsu H; Takahashi Y; Shimoyama Y; Doisaki S; Nishio N; Ito Y; Hama A; Shimada A; Yagasaki H; Ito M; Kojima S
Int J Hematol; 2011 Jun; 93(6):779-781. PubMed ID: 21559814
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
Kuriyama T; Kawano N; Yamashita K; Ueda A
J Clin Exp Hematop; 2014; 54(2):149-53. PubMed ID: 25318948
[TBL] [Abstract][Full Text] [Related]
4. Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder.
Hirokawa M; Kawabata Y; Fujishima N; Yoshioka T; Sawada K
Int J Hematol; 2007 Oct; 86(3):291-2. PubMed ID: 17989001
[No Abstract] [Full Text] [Related]
5. Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.
Wakabayashi S; Ohashi K; Hanajiri R; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Intern Med; 2010; 49(10):931-5. PubMed ID: 20467179
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.
Meyer SC; Medinger M; Halter JP; Baldomero H; Hirsch HH; Tzankov A; Dirnhofer S; Passweg JR; Tichelli A
Hematology; 2014 Jul; 19(5):280-5. PubMed ID: 24074746
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-related post-transplant lymphoproliferative disorder occurring after bone marrow transplantation for aplastic anemia in Down's syndrome.
Furuya A; Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2014; 7(1):438-42. PubMed ID: 24427369
[TBL] [Abstract][Full Text] [Related]
9. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders presented as interstitial pneumonia; successful recovery with rituximab.
Kunitomi A; Arima N; Ishikawa T
Haematologica; 2007 Apr; 92(4):e49-52. PubMed ID: 17562592
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.
Reddiconto G; Chiusolo P; Fiorini A; Farina G; Laurenti L; Martini M; Marchetti S; Fadda G; Leone G; Sica S
Leukemia; 2007 Dec; 21(12):2552-4. PubMed ID: 17597809
[No Abstract] [Full Text] [Related]
12. Recipient-derived EBV-positive Monomorphic Plasmacytoma Type Posttransplant Lymphoproliferative Disorder After Allogeneic Stem Cell Transplant for Severe Aplastic Anemia: A Case Report.
Carden MA; Caltharp S; Yee ME; Haight AE; Westblade LF; Park S
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e310-e314. PubMed ID: 27403771
[TBL] [Abstract][Full Text] [Related]
13. Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy.
Castagnola E; Dallorso S; Faraci M; Morreale G; Di Martino D; Cristina E; Scarso L; Lanino E
J Hematother Stem Cell Res; 2003 Feb; 12(1):9-10. PubMed ID: 12662431
[No Abstract] [Full Text] [Related]
14. Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.
Cooles FA; Jackson GH; Menon G; Isaacs JD
Rheumatology (Oxford); 2011 Apr; 50(4):810-2. PubMed ID: 21208978
[No Abstract] [Full Text] [Related]
15. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy.
Johnston A; Salles G; Espinouse D; Felman P; André P; Berger F; Coiffier B
Clin Lymphoma Myeloma; 2008 Dec; 8(6):356-8. PubMed ID: 19064401
[TBL] [Abstract][Full Text] [Related]
17. T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia.
Wang LC; Lu MY; Yu J; Jou ST; Chiang IP; Lin KH; Lin DT
Bone Marrow Transplant; 2000 Oct; 26(8):893-7. PubMed ID: 11081391
[TBL] [Abstract][Full Text] [Related]
18. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia.
Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J
Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder of plasma cell type following allogeneic haemopoietic stem cell transplant treated with rituximab.
Getta B; Kwan J
Intern Med J; 2014 Aug; 44(8):821. PubMed ID: 25081050
[No Abstract] [Full Text] [Related]
20. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
Yagi T; Ishikawa J; Aono N; Yamashita Y; Kusakabe S; Yoshinami T; Akazawa Y; Sakai D; Yamamoto S; Hamanaka Y; Masaie H; Sugimoto N; Yoshida H; Tomita Y; Imamura F
Int J Hematol; 2012 Feb; 95(2):214-6. PubMed ID: 22170229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
